Denali Advisors’s Phibro Animal Health PAHC Stock Holding History

Denali Advisors’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.8M	Buy	57,277 +41,328	+259%	+$1.74M	0.18%	134
2026 Q1	$882K	Buy	+15,949	New	+$759K	0.1%	193
2021 Q4	–	Sell	-21,900	Closed	-$472K	–	403
2021 Q3	$472K	Sell	21,900 -8,000	-27%	-$193K	0.2%	120
2021 Q2	$864K	Hold	29,900	–	–	0.33%	79
2021 Q1	$730K	Buy	29,900 +16,500	+123%	+$373K	0.22%	130
2020 Q4	$260K	Hold	13,400	–	–	0.04%	231
2020 Q3	$233K	Hold	13,400	–	–	0.05%	235
2020 Q2	$352K	Buy	13,400 +5,400	+68%	+$134K	0.07%	226
2020 Q1	$193K	Buy	+8,000	New	+$196K	0.04%	204
2019 Q2	–	Sell	-19	Closed	-$1K	–	321
2019 Q1	$1K	Sell	19 -30	-61%	-$934	﹤0.01%	252
2018 Q4	$2K	Hold	49	–	–	﹤0.01%	210
2018 Q3	$2K	Buy	+49	New	+$2.31K	﹤0.01%	226
2018 Q2	–	Sell	-80	Closed	-$3K	–	297
2018 Q1	$3K	Buy	80 +70	+700%	+$2.59K	﹤0.01%	203
2017 Q4	$0	Hold	10	–	–	﹤0.01%	291
2017 Q3	$0	Sell	10 -69	-87%	-$2.59K	﹤0.01%	288
2017 Q2	$3K	Buy	+79	New	+$2.58K	﹤0.01%	193

Other funds holding PAHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Denali Advisors's PAHC Position: Q2 2026 in Review

Denali Advisors increased its Phibro Animal Health (PAHC) stake by 259% in Q2 2026, buying an estimated $1.74M and bringing the position to 57,277 shares worth $1.8M. The position accounts for 0.18% of the portfolio, ranked #134.

Denali Advisors first reported a position in PAHC in Q2 2017 and has held it in 16 quarters since. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

Denali Advisors held 57,277 shares of Phibro Animal Health worth $1.8M as of Q2 2026.
Denali Advisors bought 41,328 Phibro Animal Health shares in Q2 2026, an estimated $1.74M.
Phibro Animal Health made up 0.18% of Denali Advisors's portfolio in Q2 2026, its #134 holding.
Denali Advisors first reported a position in Phibro Animal Health in Q2 2017 and has held it in 16 quarters since.
208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Denali Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.